Parental Perspective of the Benefits of Genetic Testing in Children with Congenital Deafness

Abstract

Aim: The aim of the study was to assess the perceived value of genetic testing for congenital deafness in families attending a clinical genetic outpatients department at a children’s hospital. The major testing objective was to provide information regarding deafness etiology, although families were advised that changes in treatment as a result of the test were unlikely. Using a ‘willingness-to-pay’ approach in the form of a questionnaire developed by Ryan et al. [J Med Genet 2003;40:1–5], parents were surveyed for their attitudes and willingness to pay for genetic testing. Results: Forty-nine families provided data for analysis, representing 56% of clinic attendances throughout the period. Most of the parents were themselves unaffected by hearing loss (93%) and none were deaf, although almost a quarter (22%) reported a family member born deaf. Parents considered the major benefit gained from testing was to better achieve clarity of understanding arising from discussion and the possible ascertainment of etiology. The average sum parents were willing to pay for genetic testing was 200 Australian dollars (AUD, 2007) or approximately 123 euros (EUR), ranging from 150 to 295 AUD according to ability to pay (as measured by gross income). However, the amount that even the highest income level were willing to pay underestimated the full economic cost of genetic testing. Conclusion: Genetic testing for deafness is highly valued by affected families despite the current limited overall expectation of definitive genetic diagnosis or changes in treatment. Parents considered the major benefits to be a better understanding of congenital deafness and the potential for assignment of causality.

Patient reported outcomes and patient empowerment in clinical genetics services

“…In total, Search 1 identified 2424 records (Appendix S2). Title and abstract screening excluded 2379 records and the remaining 45 full‐text articles were retrieved and assessed for eligibility . This led to inclusion of 39 studies that used both quantitative and qualitative study designs.…”

Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development

“…In our cohort of 14 patients, a diagnosis was identified in 9 of 14 (64%). Parents with children afflicted with a genetic disease place a high value on obtaining a genetic diagnosis, even with the knowledge that a diagnosis is not reached in all cases and that identification of the genetic lesion will not necessarily affect medical management . By establishing a primary genetic diagnosis, the patient is spared a long and difficult diagnostic process including numerous costly and sometimes invasive tests.…”

The Information Content of the WTP-WTA Gap: An Empirical Analysis Among Severely Ill Patients

“…The ability of respondents to accept a CV questioning in a context of high health benefits had already been partially investigated in the literature. A dozen studies had conducted WTP questioning on health programs with major consequences either on psychical or physical well-being of respondents' quality of life or on their life expectancy (e.g., recently Geelhoed et al, 2009;Radtke et al, 2009;Iskedjian et al, 2009;Saulo et al, 2008;Chuck et al, 2008;Lacour et al, 2008;Khanna et al, 2008;Bishai et al, 2008).…”